ANIMATION

Palovarotene MOA

Share this animation:

Fibrodysplasia ossificans progressiva, or FOP, is an extremely rare and debilitating disorder, in which bone tissue gradually replaces soft tissue throughout the body, extending the skeleton and “freezing” patients into position. FOP is an autosomal dominant disorder, and is believed to be caused by a mutation in the ACVR1 gene, which results in constitutively active BMP signaling. Clementia Pharmaceuticals is investigating Palovarotene as a RAR-gamma agonist capable of inhibiting BMP signaling, which may prevent heterotopic ossification and slow the progression of this devastating disease.

Share It:
Contact XVIVO

Client


Palovarotene MOA

The creation of truly effective science animations requires a community of scientists and multimedia professionals where mutual trust and respect is a given. The leaders at XVIVO bring the creativity and collaborative spirit necessary to hold such a community together and enable innovation in science visualization.

Robert Lue, Director of Life Sciences Education, Professor of the Practice of Molecular and Cellular Biology, Harvard University
Share this animation: